Bacteria that are resistant to antibiotics not only endanger lives but also affect the health system: they can generate up to $ 3.5 billion in annual spending in 2050 in each OECD country, according to a report released Wednesday.
Ending excessive antibiotics can be one step to fight bacteria.
"This bacterium is more expensive than flu, rather than AIDS, than tuberculosis. And the cost will be more expensive if the state does not act to solve this problemMichele Cechini, a public health specialist at the OECD (Organization for Economic Cooperation and Development) told AFP.
According to him, countries have devoted an average of 10% of their health budget to the treatment of antibiotic-resistant bacteria.
According to projections in the report, which concerns 33 of the 36 OECD countries, resistant bacteria can kill 2.4 million people in Europe, North America and Australia by 2050.
A separate study, published on Monday in the journal The Lancet Infectious Diseases, counted up to 33,000 deaths caused by these bacteria in 2015 in the European Union.
However, we can fight them with "simple steps" at a medium cost, according to the OECD: "encourage better cleanliness"(by encouraging, for example, washing one's hands),"end excessive prescription of antibiotics"or generalizing rapid diagnostic tests to determine whether a viral infection (in this case an antibiotic is useless) or bacteria.
According to the OECD, these measures will cost only $ 2 per person per year and prevent three-quarters of deaths.
"Investing in a large public health program that incorporates several of these steps can be amortized in one year and will result in savings of $ 4.8 billion annually", OECD judge.
Health authorities, starting with the World Health Organization (WHO), regularly warn about the dangers of excessive consumption of antibiotics, which make bacteria resistant to resistance. Small children and parents are very risky.
"In Brazil, Indonesia and Russia, between 40 and 60% of infections are resistant, compared to an average of 17% in OECD countries", emphasizing the latter.
More worrying, "second or third line antibiotic resistance is estimated to be 70% higher in 2030 compared to 2005This antibiotic is, however, what should be used as a last resort, when there is no other solution.
Starting November 8, 2018
Raising the Tideb Superbug – OECD – 7 November 2018 (report available online)